News Clinical Trial led by EMBARC Reveals Potential of Novel Antibody Therapy against Pseudomonas in Patients with Bronchiectasis – Results from the GREAT-2 Study Read More » 19 May 2025
News A breakthrough for bronchiectasis: the results of the Phase III ASPEN trial are published Read More » 25 April 2025
